Profile
Elizabeth Homans is currently the Chief Executive Officer at Immulus, Inc. and also serves as the Director at Delfi Diagnostics, Inc. She was previously the Chief Executive Officer & Director at Lyell Immunopharma, Inc. and Executive Director-Project Leadership at Jazz Pharmaceuticals, Inc. Ms. Homans holds an MBA from The Trustees of Columbia University in The City of New York and an undergraduate degree from Bates College.
Elizabeth Homans active positions
| Companies | Position | Start |
|---|---|---|
Immulus, Inc.
Immulus, Inc. Pharmaceuticals: MajorHealth Technology Manufactures cell therapies | Chief Executive Officer | - |
Delfi Diagnostics, Inc.
Delfi Diagnostics, Inc. BiotechnologyHealth Technology Develops AI-powered liquid biopsy tests using fragment omics technology to help detect cancer early through simple blood draws | Director/Board Member | 2022-03-29 |
Former positions of Elizabeth Homans
| Companies | Position | End |
|---|---|---|
| LYELL IMMUNOPHARMA, INC. | Chief Executive Officer | 2022-12-14 |
Jazz Pharmaceuticals, Inc.
Jazz Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets pharmaceutical products | Corporate Officer/Principal | 2007-10-31 |
Education of Elizabeth Homans
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 6 |
|---|---|
Jazz Pharmaceuticals, Inc.
Jazz Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets pharmaceutical products | Health Technology |
The Trustees of Columbia University in The City of New York
The Trustees of Columbia University in The City of New York Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Bates College
Bates College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Lyell Immunopharma, Inc.
Lyell Immunopharma, Inc. BiotechnologyHealth Technology Develops cell-based immunotherapies for human diseases | Health Technology |
Delfi Diagnostics, Inc.
Delfi Diagnostics, Inc. BiotechnologyHealth Technology Develops AI-powered liquid biopsy tests using fragment omics technology to help detect cancer early through simple blood draws | Health Technology |
Immulus, Inc.
Immulus, Inc. Pharmaceuticals: MajorHealth Technology Manufactures cell therapies | Health Technology |
- Stock Market
- Insiders
- Elizabeth Homans
















